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Abstract
Genetics of the variability of normal and diseased brain structure largely remains to be elucidated. Expansions of certain
trinucleotide repeats cause neurodegenerative disorders of which Huntington’s disease constitutes themost common example.
Here, we test the hypothesis that variation within the IT15 gene on chromosome 4, whose expansion causes Huntington’s
disease, influences normal human brain structure. In 278 normal subjects, we determined CAG repeat length within the IT15
gene on chromosome 4 and analyzed high-resolution T1-weighted magnetic resonance images by the use of voxel-based
morphometry. We found an increase of GM with increasing long CAG repeat and its interaction with age within the pallidum,
which is involved in Huntington’s disease. Our study demonstrates that a certain trinucleotide repeat influences normal brain
structure in humans. This result may have important implications for the understanding of both the healthy and diseased brain.
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Introduction
Knowledge on the genetic determination of normal brain structure
is limited. Trinucleotide repeats refer to a short DNA tract in which
the same sequence of 3 base pairs is repeated several to many times in
tandem. This genetic variation may influence normal brain structure
in humans since it contributes to variation in behavioral traits in
animals [1] and causes a number of neurodegenerative disorders in
humans of which Huntington’s disease (HD) constitutes the most
common example. This autosomal-dominant disorder results from an
expanded CAG trinucleotide repeat size (.35) within the first exon of
the IT15 gene on chromosome 4 leading to a polyglutamin stretch.
HD is characterized by the triad of involuntary movements, dementia,
and behavioral disturbances [2]. Of note, symptoms become more
severe and start earlier in life with increasing trinucleotide repeat size,
and brain atrophy is pronounced within subcortical structures [2].
Here, we test the hypothesis that normal CAG repeat size influences
brain structure in normal human subjects. In analogy to HD, we
determined the influence of the longer CAG on subcortical structures
and expected this effect to increase with age.
Methods
1. Subjects
The MRI images of 278 normal subjects (females, 130; age
range, 18–65 years; mean6standard deviation, 34612; 25th/
50th/75th percentile, 25/30/41) that had served as healthy
controls in several imaging studies (Department of Psychiatry
and Psychotherapy, Ludwig-Maximilians University, Munich,
Germany) were analyzed. For the respective studies, all subjects
underwent a structured interview and neuropsychiatric evalu-
ation. Exclusion criteria were a history of known neurological
or mental illness including first degree relatives as well as
previous head injury with loss of consciousness, corticosteroid
medication in the medical history, previous alcohol or other
substance abuse, and other mental illnesses including person-
ality disorders. Beforehand, written informed consent was
obtained after description of the respective study to the
subjects. The studies were approved by the ethics committee
of the medical faculty of the Ludwig-Maximilians-University
Munich, and performed in accordance with the Declaration of
Helsinki.
2. Magnetic resonance imaging
All brain images were acquired on the same 1.5T scanner
(Magnetom Vision; Siemens, Erlangen, Germany) including a 3-
dimensional magnetization prepared rapid acquisition gradient
echo sequence (repetition time, 11.6 milliseconds; echo time,
4.9 milliseconds; total acquisition time, 9 minutes; number of
acquisitions, 1; field of view, 230 mm; matrix, 5126512 pixels;
and section thickness, 1.5 mm).
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3. Voxel-based morphometry
For voxel-based morphometry (VBM), we used an extension
of the SPM8 software (http://www.fil.ion.ucl.ac.uk/spm), the
VBM8 toolbox (http://dbm.neuro.uni-jena.de/vbm8). Here,
images are corrected for bias-field inhomogeneities, registered
using linear (12-parameter affine) and nonlinear transforma-
tions, as well as tissue-classified into grey matter (GM), white
matter (WM), and cerebrospinal fluid (CSF) within the same
generative model [3]. The segmentation procedure is further
refined by high dimensional warping also called ‘‘DARTEL’’
[4], by accounting for partial volume effects [5], by adaptive
maximum a-posteriori estimations [6], and by a hidden Markov
random field model [7]. The resulting GM images were
modulated to account for volume changes resulting from the
normalization process. We considered only non-linear volume
changes so that further analyses did not have to account for
differences in head size. Finally images were smoothed with a
Gaussian kernel of 8 mm (FWHM).
4. Measurement of CAG repeat size
Fragment analysis was performed using the following primer
pair CCTTCGAGTCCCTCAAGTCCTT (forward), GGTGG-
CGGCTGTTGCTGCTGC (reverse), which do not amplify the
CCG-repeat adjacent to the CAG-repeat and analyzed on an ABI
3730 sequencer using LIZ-500 (ABI) as a standard. Analysis was
performed using GeneMapper v3.5 [8].
5. Statistical analysis
For each subject, determination of the CAG repeat size yielded
2 values. In analogy to HD, we expected the longer CAG repeat to
be primarily efficacious with regard to brain structure and even
more so with increasing age. We used a voxel-wise general linear
model (GLM) as implemented in SPM8. The main effect of a
variable corresponds to a linear positive or negative relationship
with GM. To estimate the main effect of a variable, a contrast is
defined in which each variable is weighted. The weight of the
variable of interest is set 1 to search for positive correlations and
21 to search for negative correlations whilst the remaining
variables are not weighted (weight, 0) so that variance explained by
these remaining variables (nuisance variables) are removed prior to
estimation of significance. To search for the interaction of two
variables, both variables as well as the interaction term (i.e. the
product of both variables) are included in the GLM. Now, only the
interaction term is weighted (again 1 or 21). This way, variance
merely explained by the main effects will be removed so that only
the interaction of the two variables is estimated. Intriguingly, an
interaction with age will possibly result in the mere finding of a
main effect if the age range of the subjects under investigation is
unsuitable to detect this interaction. Since we had no hypothesis
on the age at which such an interaction comes into play, we
predefined the combined measure of the main effect of long CAG
repeat and its interaction with age as the primary endpoint. As
secondary endpoints, we determined the main effect of long CAG
repeat and its interaction with age separately. For clarity, we will
first describe the model to determine the main effect (1), then the
model to determine the mere interaction with age (2), and, finally,
the model to determine the primary endpoint, i.e. the combination
of the first two effects. 1) The main effect of the long CAG repeat
was estimated by inclusion of long CAG repeat, age, and sex; then,
long CAG repeat size was weighted. 2) The interaction of the long
CAG repeat with age was estimated by inclusion of long CAG
repeat6age, long CAG repeat, age, and sex; then, CAG
repeat6age was weighted. 3) The combined effect of 1) and 2)
was estimated by inclusion of long CAG repeat6age, age, and sex
(but not long CAG); then, long CAG repeat6age was weighted.
We expected changes that, compared to HD, are of relatively
small effect size and located within subcortical areas since, in HD,
atrophy is most pronounced here. Hence, we performed a region
of interest (ROI) analysis. This single and bilateral ROI included
the striatum, pallidum, and thalamus. Since structural variance
explained by the long CAG repeat size in normal subjects must not
necessarily be pronounced in regions, which primarily display GM
loss in HD, we also performed a whole brain analysis. We applied
a height threshold (voxel level) of p,0.05 corrected according to
the family-wise error [9].
For exploratory analyses, we relaxed the height threshold (voxel
level) to 0.01 and 0.05 uncorrected. Now, we considered the
corresponding area of the opposite hemisphere and also
determined P values derived from both cluster level inference
(extent threshold), which gives a single p value for each observed
cluster, and set level interference, which gives a single p value for
all observed clusters [9]. Beforehand, data were corrected for
inhomogeneity of smoothness which is necessary for cluster size
analyses of VBM data in particular [10].
In retrospect (during the course of the review process), we
performed the same analyses with regard to the effect of the short
CAG repeat.
Location of basal ganglia structures was assessed according to
the Harvard-Oxford subcortical structural atlas (http://www.
fmrib.ox.ac.uk/fsl/data/atlas-descriptions.html).
Results
Within the margins published so far [11], CAG repeat sizes
ranged from 9 to 32 (mean6SD, 18.463.2).
ROI analysis of the primary endpoint, i.e. the combined effect
of long CAG repeat and its interaction with age, revealed a cluster
of 21 voxels of increased GM with increasing long CAG repeat
and its interaction with age within the left pallidum (Fig. 1A,
Table 1). Exploratory whole brain analysis at the uncorrected
height threshold of 0.01 revealed a large cluster of GM increase,
which survived whole brain correction at the cluster level
(p = 0.003) and which reached from the pallidum across parts of
the ventral thalamus to the midbrain (Fig. 1A). Both the right and
left hemispheric maximum were located within the pallidum. Slice
by slice comparison with standard atlases of the human brain stem
[12,13] revealed bilateral overlap with the nucleus subthalamicus
and substantia nigra.
ROI analysis of the main effect of long CAG (secondary
endpoint) yielded 3 contiguous voxels of significant GM increase
with increasing long CAG repeat within the left pallidum (Fig. 1B,
Table 1). Relaxing the significance threshold to 0.05 uncorrected
suggested GM increase also within the right pallidum (p= 0.037
uncorrected, not shown).
ROI analysis of the interaction of long CAG with age
(secondary endpoint) showed no significant results according to
defined significance thresholds. However, at the uncorrected
height threshold of 0.01, we observed small clusters of increasing
GM with increasing interaction that resulted in a corrected P value
of 0.023 at the set level (Fig. 1C, Table 1). Further, decreasing the
height threshold to 0.05 yielded a cluster, which overlapped with
the peak voxel derived from the analysis of the main effect of long
CAG.
None of the GM increases detected survived whole brain
correction for multiple statistical tests at the voxel level. We did not
observe any GM decrease. Subsequent analyses of the effect of the
short CAG repeat did not yield any significant result.
Huntington’s Gene and Normal Brain Structure
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Figure 1. Projections of coronal (upper row) and axial (middle row) slices onto the SPM template as well as maximum intensity
projections (lower row) are shown. MNI coordinates are indicated in the left upper corners. Increasing significance (T score) is color-coded from
dark red to light yellow as indicated by the bar in the center. Note that only the clusters marked with a red rectangle contain peak voxels, which
remained significant after correction for multiple comparisons at the voxel level. For better visibility, all results (including those from exploratory
analyses) are shown at a height threshold of 0.01 uncorrected. Cluster sizes were restricted to 20 contiguous voxels for ROI analyses or subjected to
cluster level correction (p,0.05 corrected) for the whole brain analysis. A) Combined effect of long CAG & its interaction with age, ROI analysis (left)
and whole-brain analysis (right) revealing one bilateral cluster reaching from the pallidum across parts of the ventral thalamus to the midbrain
(corrected P value at the cluster level, 0.003). B) Main effect of the long CAG, ROI analysis. C) Interaction analysis of long CAG with age, ROI analysis.
doi:10.1371/journal.pone.0029809.g001
Table 1. Influence of long CAG and age on cerebral gray matter.
Region MNI coordinates (peak) P values
voxel level (corrected for ROI) voxel level uncorrected
Primary endpoint: combined effect of long CAG and its interaction with age
(Contrast weights: long CAG6age, 1; age, 0; sex, 0)
Pallidum L 217 28 23 0.007 8.461026
Pallidum R 20 212 2 0.11 0.0003
Secondary endpoint: main effect of long CAG
(Contrast weights: long CAG, 1; age, 0; sex, 0)
Pallidum L 217 28 23 0.02 4.461025
Pallidum R 18 25 22 0.8 0.037
Secondary endpoint: effect of interaction of long CAG and age
(Contrast weights: long CAG6age, 1; CAG, 0; age, 0; sex, 0)
Pallidum L 220 0 26 0.2* 0.0005
Pallidum R 21 211 0 0.08* 0.0001
Note. L, left; R, right;
*corrected P value at the set level, 0.023.
doi:10.1371/journal.pone.0029809.t001
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Discussion
We investigated the effect of the CAG repeat length in normal
subjects and demonstrated an increase of GM within the left
pallidum as the long CAG repeat and its interaction with age
increased. In this way, we showed that the variability of the CAG
repeat length within the normal range influences brain structure in
normal humans. We first reason why we focused on the long CAG
repeat and its interaction with age; next, we critically discuss
methodological issues. Finally, we consider possible implications
for the understanding of HD, although variation within other
trinucleotide repeats may also influence human brain structure.
Before data analysis, we reasoned that, in analogy to HD, the
long CAG is primarily efficacious with regard to brain structure.
Besides, in our draw of images, the short CAG repeat size
correlated with age by chance (Pearson’s coefficient, 20.14; 2-
sided P value, 0.019) so that it seemed hardly possible to
disentangle the effect of the short CAG from that of age. Further,
we did not focus on the interaction of the short and long CAG
repeat length since, again in analogy to HD, we expected it to be
less efficacious [14,15,16,17]. Of note, short and long CAG repeat
correlated significantly (Pearson’s coefficient, 0.33; 2-sided P value,
,0.001) which is well conceivable as only a large long CAG repeat
implies the possibility of a ‘‘large’’ short CAG repeat (since the
latter would otherwise constitute the long CAG repeat). This
dependence also implied a significant correlation of the long CAG
repeat with the difference from the long and short CAG repeat
(Pearson’s coefficient, 0.82; 2-sided P value, ,0.001) so that our
data are inappropriate to study differential effects of the two CAG
repeat lengths and their interaction. In contrast, age and long
CAG repeat size were not correlated (Pearson’s coefficient, 0.013;
2-sided P value, 0.8) but almost orthogonal so that our data were
suitable to analyze the interaction of long CAG repeat size and
age. Our assumption on this interaction was not only based on the
fact that HD is a neurodegenerative and, hence, progressive
disease but also on knowledge about normal Huntingtin whose
increased expression leads to protection from apoptotic neuronal
cell death after toxic stimuli, neuroprotection from excitotoxicity,
and increased transcription of brain-derived neurotrophic factor
[18]—all characteristics that may well interfere with the process of
aging. Yet our detailed analyses indicated that the interaction of
long CAG repeat size with age was minor compared to the main
effect of the long CAG repeat (i.e. an increase of GM with
increasing long CAG) which may result from the age distribution
of our population that was relatively young (75%, ,41 years).
Statistical analyses of MRI data throughout the whole brain are
conservative given the need to correct for multiple statistical tests.
Consequently, ROI analyses are commonly applied. This
approach is justified by empirical results from imaging genetics
that found no relationship between certain ROIs and false
positives [19]. Still ROI analyses are only acceptable if this
particular region was predicted in advance [9]. Thus, ROI
selection requires critical assessment. We included the striatum
since the medium spiny neurons of this basal ganglia structure are
most affected in HD [2] so that we expected GM changes to be
most striking here. We also included the pallidum and thalamus
since medium spiny neurons mainly project to the pallidum and,
from there, to the thalamus [20]. Accordingly, disturbance of the
indirect and direct pathway is commonly assumed in HD, and
pronounced GM loss within the pallidum and thalamus has been
described [21,22]. Of note, evidence exists that even points to an
influence of the normal CAG repeat size on pallidum structure in
HD. Aziz et. al. investigated HD patients with regard to the
influence of the normal CAG repeat size (i.e., the CAG repeat size
of the chromosome homologous to the mutant chromosome) on
the course of the disorder and demonstrated an interaction of the
expanded (mutant) CAG repeat with its normal counterpart [14]
although others could not completely replicate this finding [16].
Preliminary data of MRI scans from 16 patients even indicated a
main effect of the normal CAG repeat on basal ganglia structures
(i.e. a linear negative relationship between normal CAG repeat
and pallidum volume) which was most pronounced within the
pallidum [14]. In our primary endpoint analysis however, only
parts of the left pallidum survived correction for multiple statistical
tests. On the other hand, analyses of the secondary endpoints
yielded plausible results supporting our main finding. Relaxing the
statistical significance threshold suggested a main effect of long
CAG also within the right pallidum (i.e. an increase of GM with
increasing long CAG). Moreover, interaction analysis of long CAG
with age yielded clusters overlapping with those of the main effect
analysis resulting in a set level P value of 0.023 although the result
of this interaction analysis is independent from that of the main
effect analysis. Further, exploratory whole brain analysis of the
primary endpoint, the combined effect of the long CAG repeat
and its interaction with age, at the height threshold of 0.01
(Fig. 1C) yielded a single cluster, which survived whole-brain
correction (cluster level), largely overlapped with our ROI and,
thus, with regions critically involved in HD. Besides the pallidum,
we detected parts of the ventral thalamus (station of the direct and
indirect pathway) as well as parts of the mesencephalon
(overlapping with the nucleus subthalamicus, a station of the
indirect pathway, and substantia nigra which exerts a modulatory
effect on both the direct and indirect pathway). Finally,
‘‘conventional’’ structural T1-weighted MRIs, as used here, may
not provide sufficient contrast for reliable automated segmentation
accuracy of subcortical structures including the pallidum [23]
although others could identify GM changes within the pallidum in
asymptomatic heterozygous Parkin mutation carriers [24]. Of
note, our segmentation algorithm accounts for partial volume
effects [5]. Yet we considered the mean GM value of our peak
voxel (MNI coordinates 217 28 3) in retrospect. This calculation
yielded a value of 0.360.0084 (mean6SD) indicating a sufficient
amount of GM detected by the methods applied here. Still, we
acknowledge as a limitation of our methodology that GM
segmentation within the pallidum was not as accurate as for most
cortical regions and the striatum where values ranged around 0.8.
Next, we will briefly review on Huntingtin, the gene product of
IT15 and consider possible implications of our finding for the
understanding of HD [25]. Given that Huntingtin is expressed
across and outside the brain and that neither the physiological nor
pathological role is fully understood, we are far from a unifying
model of HD’s pathophysiology. Nevertheless, the understanding
of normal Huntingtin’s function has been regarded an important
approach to HD because of several experimental findings:
increased expression of normal Huntingtin improves brain cell
survival; removal of normal Huntingtin generates some of the
phenotypes also observed in the presence of mutant Huntingtin;
normal Huntingtin expression mitigates the effect of the mutant
protein; and deletion of the normal allele in an animal model of
HD causes more damage [18]. The function of Huntingtin at the
molecular level is less clear however. It is a soluble protein of 3,144
amino acids with many potential domains. CAG repeats are
translated into the polyglutamine tract (polyQ) near the N-
terminal. This portion forms a polar zipper [26] suggesting a
physiological function to bind—assumingly numerous—transcrip-
tion factors that also contain a polyQ region. Differences in CAG
repeat size and, hence, the polyQ region may alter this binding
through conformational changes, which is a testable hypothesis.
Huntington’s Gene and Normal Brain Structure
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Within the normal range, subtle structural changes may result
whilst, in HD, the profile of respective binding partners may be
altered dramatically leading to cytotoxicity. On the other hand, it
also seems possible that normal CAG repeat size influences
functions that facilitate or mitigate HD symptoms at the systemic
level. Since longitudinal VBM studies demonstrated that an
increased signal goes along with increased functional capacity
[27,28], our finding of increased GM within structures attributable
to the indirect pathway may imply a predisposition to hyperkine-
sia. In HD, mild to moderate CAG increase goes along with
hyperkinesia and later onset. Hence, long normal CAG repeat size
could aggravate symptoms in these patients. In contrast, high
mutant CAG repeat size results in hypokinesia and earlier onset so
that high normal CAG repeat size could antagonize and, hence,
mitigate symptoms. Of note, latest evidence of an effect of the
normal CAG repeat size on the course of HD points in the same
direction. A long normal CAG size increased pathogenicity (i.e.
earlier onset of symptoms) in patients with an expansion of ,44
CAG repeats whilst a long normal CAG repeat size exerted a
protective effect in patients with an expansion of .44 CAG
repeats (i.e. later onset of symptoms) [14]. These considerations
raise the question whether normal CAG repeat size plays a role for
any other phenotype than HD? Such evidence does not yet exist
however. Schizophrenia [29], affective disorders [30,31], and
Parkinson’s disease [32] could be related to neither increased nor
decreased CAG repeat size.
In summary, we demonstrated that CAG repeat length within
IT15 influences normal brain structure in humans. This finding
may help to understand variation of human brain structure in both
health and disease.
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